Institutional Ownership
Protalix Biotherapeutics Inc
CUSIP 74365A309COMPLXQ1 2026
13D / 13G Filings
24
Schedule 13D/13G on record
Beneficial Filers
10
Distinct reporting persons
Largest Stake
10.3%
Max % of class reported
Institutional Holders
97
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
24 filings · latest Mar 4, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 4, 2026 | Mak Capital Fund LP | 13G | 5.8% | 4.65M | SEC |
| 2 | Oct 25, 2024 | Whitebox Advisors LLC | 13G/A | — | — | SEC |
| 3 | Jan 2, 2024 | Nacht Marius | 13G/A | 2.9% | 2.21M | SEC |
| 4 | Jan 3, 2023 | Nacht Marius | 13G/A | 5.3% | 2.82M | SEC |
| 5 | Jun 9, 2022 | Whitebox Advisors LLC | 13G | 5.7% | 2.82M | SEC |
| 6 | Feb 14, 2022 | Highbridge Capital Management LLC | 13G/A | 5.0% | 2.41M | SEC |
| 7 | Feb 11, 2022 | Highbridge Capital Management LLC | 13G/A | — | — | SEC |
| 8 | Jan 31, 2022 | Nacht Marius | 13G/A | 5.8% | 2.82M | SEC |
| 9 | Jul 30, 2021 | Burrage Capital Management LLC | 13G/A | — | — | SEC |
| 10 | Jun 15, 2021 | Dexcel Pharma Technologies Ltd. | 13G/A | 4.5% | 2.03M | SEC |
14 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Protalix Biotherapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 3.62M | $7.85M |
| 2 | Mak Capital One LLC | 3.54M | $7.69M |
| 3 | Renaissance Technologies LLC | 1.22M | $2.66M |
| 4 | State Street Corp | 972.8K | $2.11M |
| 5 | Northern Trust Corp | 885.4K | $1.92M |
| 6 | Geode Capital Management, LLC | 865.3K | $1.88M |
| 7 | Stratos Wealth Partners, Ltd. | 500.0K | $1.08M |
| 8 | Prospera Financial Services Inc | 418.6K | $908.3K |
| 9 | Opaleye Management Inc. | 340.0K | $737.8K |
| 10 | Morgan Stanley | 301.8K | $654.9K |